IRWD IRONWOOD PHARMACEUTICALS INC
Nasdaq · SEC CIK 1446847 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $22.50M 11 sales by 8 insiders
- Filings on record
- 207 since 2021-07-22, latest 2026-09-17 16:05
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| DENNER ALEXANDER J | Dir, 10% | — | $20.53M |
| Silver Ronald | Principal Accounting Off | — | $831.2K |
| MCCOURT Thomas A | CEO, Dir | — | $739.9K |
| John Minardo | CLO | — | $136.2K |
| Gaskins Tammi L | Chief Commercial Off | — | $100.3K |
| Martini Gregory S. | CFO | — | $81.9K |
| McHugh Julie | Dir | — | $80.5K |
| Silber Jeffrey | SVP, CMO, Head-Res, Drug | — | — |
| Moukheibir Catherine | Dir | — | — |
| Duane Jon R | Dir | — | — |
Transactions 219
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-21 | 2022-01-19 | IRWD | Shetzline Michael | CMO, SVP, Head-Res, Drug | A - Grant | $0.00 | +29.3K | 213.0K | +16% | $0 | |
| 2021-12-23 | 2021-12-22 | IRWD | MCCOURT Thomas A | CEO, Dir | S - Sale | $11.41 | -46.3K | 574.5K | -7% | -$528.6K | |
| 2021-12-20 | 2021-12-16 | IRWD | Rickard Jason | SVP, COO | S - Sale | $11.28 | -27.0K | 319.9K | -8% | -$304.6K | |
| 2021-12-17 | 2021-12-15 | IRWD | Moukheibir Catherine | Dir | A - Grant | $0.00 | +1,541 | 76.3K | +2% | $0 | |
| 2021-12-17 | 2021-12-15 | IRWD | Sarissa Capital Management LP | 10% | A - Grant | $0.00 | +1,211 | 65.4K | +2% | $0 | |
| 2021-12-17 | 2021-12-15 | IRWD | Dreyfus Andrew | Dir | A - Grant | $0.00 | +1,431 | 130.1K | +1% | $0 | |
| 2021-12-16 | 2021-12-14 | IRWD | McHugh Julie | Dir | S - Sale | $11.02 | -10.0K | 138.4K | -7% | -$110.2K | |
| 2021-12-08 | 2021-12-06 | IRWD | Emany Sravan Kumar | SVP, CFO | A - Grant | $0.00 | +85.0K | 85.0K | New | $0 | |
| M | 2021-11-24 | 2021-11-23 | IRWD | Silver Ronald | Principal Accounting Off | S - Sale | $11.58 | -1,462 | 61.2K | -2% | -$16.9K |
| 2021-11-24 | 2021-11-23 | IRWD | MCCOURT Thomas A | CEO, Dir | S - Sale | $11.58 | -52.6K | 618.5K | -8% | -$609.6K | |
| 2021-11-24 | 2021-11-23 | IRWD | Shetzline Michael | CMO, SVP, Head-Res, Drug | S - Sale | $11.58 | -13.8K | 183.7K | -7% | -$159.5K | |
| M | 2021-11-24 | 2021-11-23 | IRWD | Rickard Jason | SVP, COO | S - Sale | $11.58 | -17.2K | 344.7K | -5% | -$199.1K |
| 2021-09-17 | 2021-09-15 | IRWD | DENNER ALEXANDER J | Dir, 10% | A - Grant | $0.00 | +1,137 | 64.2K | +2% | $0 | |
| 2021-09-17 | 2021-09-15 | IRWD | Dreyfus Andrew | Dir | A - Grant | $0.00 | +1,344 | 134.7K | +1% | $0 | |
| 2021-09-17 | 2021-09-15 | IRWD | Moukheibir Catherine | Dir | A - Grant | $0.00 | +1,447 | 74.8K | +2% | $0 | |
| 2021-08-18 | 2021-08-16 | IRWD | Rickard Jason | SVP, COO | S - Sale | $13.48 | -680 | 361.9K | -0.2% | -$9,166 | |
| 2021-08-18 | 2021-08-16 | IRWD | Silver Ronald | Principal Accounting Off | S - Sale | $13.48 | -567 | 62.7K | -0.9% | -$7,643 | |
| 2021-08-04 | 2021-08-02 | IRWD | John Minardo | CLO | A - Grant | $0.00 | +79.9K | 79.9K | New | $0 | |
| 2021-07-22 | 2021-07-20 | IRWD | Silver Ronald | Principal Accounting Off | A - Grant | $0.00 | +20.0K | 63.2K | +46% | $0 |
Purchase Sale Sale after option exercise All abbreviations